Piscalko H, Dhanani L, Brook D, Hall O, Miller W, Go V
Ann Med. 2024; 56(1):2399316.
PMID: 39234650
PMC: 11378676.
DOI: 10.1080/07853890.2024.2399316.
Fokuo J, Hutman P, Gruber V, Masson C, Lum P, Bush D
J Psychoactive Drugs. 2024; :1-11.
PMID: 38646910
PMC: 11493843.
DOI: 10.1080/02791072.2024.2343402.
Ochterbeck D, Frense J, Forberger S
Nordisk Alkohol Nark. 2024; 41(1):39-56.
PMID: 38356788
PMC: 10863558.
DOI: 10.1177/14550725231188802.
Ishida S, Nishitsutsumi Y, Kashioka H, Taguchi T, Shineha R
Front Neurosci. 2023; 17:1160611.
PMID: 37781239
PMC: 10536163.
DOI: 10.3389/fnins.2023.1160611.
Greener M, Storr S
Front Mol Neurosci. 2023; 16:1166852.
PMID: 37745284
PMC: 10511750.
DOI: 10.3389/fnmol.2023.1166852.
Grayken lessons: between a rock and a hard place? A 37-year-old man with acute liver injury while enrolled in a managed alcohol program for severe alcohol use disorder.
Brothers T, Walley A, Rivers-Bowerman H, McLeod M, Genge L
Addict Sci Clin Pract. 2023; 18(1):14.
PMID: 36879279
PMC: 9988200.
DOI: 10.1186/s13722-023-00370-5.
The Harms of Constructing Addiction as a Chronic, Relapsing Brain Disease.
Lie A, Hansen H, Herzberg D, Mold A, Jauffret-Roustide M, Dussauge I
Am J Public Health. 2022; 112(S2):S104-S108.
PMID: 35349310
PMC: 8965190.
DOI: 10.2105/AJPH.2021.306645.
Getting "clean" from nonsuicidal self-injury: Experiences of addiction on the subreddit r/selfharm.
Himelein-Wachowiak M, Giorgi S, Kwarteng A, Schriefer D, Smitterberg C, Yadeta K
J Behav Addict. 2022; 11(1):128-139.
PMID: 35312631
PMC: 9109623.
DOI: 10.1556/2006.2022.00005.
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.
Cheetham A, Picco L, Barnett A, Lubman D, Nielsen S
Subst Abuse Rehabil. 2022; 13:1-12.
PMID: 35115860
PMC: 8800858.
DOI: 10.2147/SAR.S304566.
What is a mental disorder? An exemplar-focused approach.
Stein D, Palk A, Kendler K
Psychol Med. 2021; 51(6):894-901.
PMID: 33843505
PMC: 8161428.
DOI: 10.1017/S0033291721001185.
"I Was Raised in Addiction": Constructions of the Self and the Other in Discourses of Addiction and Recovery.
Sibley A, Schalkoff C, Richard E, Piscalko H, Brook D, Lancaster K
Qual Health Res. 2020; 30(14):2278-2290.
PMID: 33148139
PMC: 7649922.
DOI: 10.1177/1049732320948829.
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.
Cooper H, Cloud D, Freeman P, Fadanelli M, Green T, Van Meter C
Int J Drug Policy. 2020; 85:102701.
PMID: 32223985
PMC: 7529684.
DOI: 10.1016/j.drugpo.2020.102701.
Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review.
Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese S
Medicine (Baltimore). 2019; 98(20):e15425.
PMID: 31096439
PMC: 6531094.
DOI: 10.1097/MD.0000000000015425.
Addiction Mindsets and Psychological Processes of Quitting Smoking.
Sridharan V, Shoda Y, Heffner J, Bricker J
Subst Use Misuse. 2019; 54(7):1086-1095.
PMID: 30892118
PMC: 6532787.
DOI: 10.1080/10826084.2018.1555259.
Free Will and the Brain Disease Model of Addiction: The Not So Seductive Allure of Neuroscience and Its Modest Impact on the Attribution of Free Will to People with an Addiction.
Racine E, Sattler S, Escande A
Front Psychol. 2017; 8:1850.
PMID: 29163257
PMC: 5672554.
DOI: 10.3389/fpsyg.2017.01850.
Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither.
Heather N
Neuroethics. 2017; 10(1):115-124.
PMID: 28725283
PMC: 5486515.
DOI: 10.1007/s12152-016-9289-0.
Views about responsibility for alcohol addiction and negative evaluations of naltrexone.
Johnson R, Lukens J, Kole J, Sisti D
Subst Abuse Treat Prev Policy. 2015; 10:10.
PMID: 25886539
PMC: 4369079.
DOI: 10.1186/s13011-015-0004-7.
Contingencies of the will: Uses of harm reduction and the disease model of addiction among health care practitioners.
Szott K
Health (London). 2014; 19(5):507-22.
PMID: 25394654
PMC: 4430440.
DOI: 10.1177/1363459314556904.